3 ms·
>No, companies will stop doing research now. That's what I'm worried about, too. For example C60 [1] is a curious molecule that can't be patented anymore. In
by kybernetyk 11y ago
>No, companies will stop doing research now.
That's what I'm worried about, too.
For example C60 [1] is a curious molecule that can't be patented anymore. In a rat study it showed to prolong the rats' lives by over 90% [2] by protecting the rats from cancer.
Sadly there won't be any human study anytime soon (if at all) because it's just not financially viable without the possibility of patenting the stuff and extracting fantasy prices for it.
[1] https://en.wikipedia.org/wiki/Buckminsterfullerene https://en.wikipedia.org/wiki/Buckminsterfullerene
[2] http://www.kurzweilai.net/fullerene-c60-administration-doubles-rat-lifespan-with-no-toxicity http://www.kurzweilai.net/fullerene-c60-administration-doubl...
- JulianMorrison 11y agoGovernments need to directly fully fund studies in promising but unpatentable medicines.
- rmc 11y agoThere's enough billionares who want to live forever. They'll fund it, if only so their own lives last longer.
- JulianMorrison 11y agoYou'd be surprised. It's hard to get people to fund SENS anti-ageing through which they could literally live forever. In general, humans don't have a survival instinct, only a "don't die right now" instinct.
- flipp3r 11y agoYou should read the comment section of the second link. The badly done research was done by someone whose business is selling snake oil with c60 in it.
- kybernetyk 11y agoHmm, interesting. Has anyone here access to the referenced paper [1] and can confirm that "Anthony Loera" worked on it? [1] http://linkinghub.elsevier.com/retrieve/pii/S0142961212003237?via=sd http://linkinghub.elsevier.com/retrieve/pii/S014296121200323... Ref.: Baati T, et al., The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene, Biomaterials (2012), doi:10.1016/j.biomaterials.2012.03.036